Media Centre

Featured Media Release

15 Apr 2014 - Illuminate your smile with the new Macleans® High Definition™ White range

Whether having a laugh with friends, showcasing ideas at a business meeting or embarking on a first date with that special someone – an illuminated smile can make you look and feel your best at all times. So light-up your day and ensure you're always presenting your best possible self with the new Macleans® High Definition™ White range, which helps illuminate your smile.


Media Releases

Indigenous and refugee programs win immunisation boost

GSK’s 2014 Immunisation Grants have been awarded to programs that are helping improve access and awareness of vaccination services for Indigenous and refugee communities.



Arzerra® (ofatumumab) registered in Australia for first-line use in chronic lymphocytic leukaemia (CLL)...

GlaxoSmithKline announced today that the Therapeutic Goods Administration (TGA) has registered Arzerra® (ofatumumab), a human monoclonal antibody, in combination with chlorambucil or bendamustine for the treatment of patients in Australia with...



International collaboration to develop inhaled form of oxytocin to manage bleeding after childbirth

GSK, Monash University, McCall MacBain Foundation, Grand Challenges Canada and Planet Wheeler Foundation join forces to develop oxytocin dry powder inhaler



Night time bathroom visits - a trigger for men to visit the doctor

New Australian campaign launched that focusses on enlarged prostates



Kimbra launches campaign to urge effective asthma management

Asthma Awareness Week – Popular recording artist and asthma sufferer Kimbra is joining forces with asthma experts and peak respiratory health groups today to launch the Asthma: Take Control campaign. The national campaign is urging people affected...



Medicines Research Unit to Close

GSK today announced it will be closing the Medicines Research Unit at the Prince of Wales Hospital in Sydney.



GSK Open Innovation brings opportunities to Australian & NZ innovators

An innovation program that helps develop ground-breaking health sector ideas around the world is calling upon Australian and New Zeland innovators to submit their ideas to the GSK Open Innovation website.



GSK Response to Publication of Paracetamol in Low Back Pain Study (PACE)

Panadol is approved by the TGA for the effective relief of backache.



New medicine for lupus now available in Australia

GSK is pleased to announce that BENLYSTA® (belimumab) is now available in Australia for use as an add-on therapy in adult patients with active, autoantibody-positive systemic lupus erythematosus (SLE) with a high degree of disease activity despite...



Incruse® Ellipta® (umeclidinium) approved in Australia for Chronic Obstructive Pulmonary Disease

GlaxoSmithKline has announced today that the Therapeutic Goods Administration (TGA) has approved Incruse® Ellipta® (umeclidinium), a maintenance treatment to relieve symptoms in Australian adult patients with chronic obstructive pulmonary disease...


1 2 3 4 5 6 7 8 9 10 11 >